Combine essential chemical engineering concepts and biological principles to address the needs of the biotech industry. The production of protein pharmaceuticals will be used as a paradigm to investigate recombinant DNA technology, synthetic biology and metabolic engineering. Develop processes and effective solutions to navigate biobusiness and regulatory issues.
Note that this course is crosslisted with CHEMENG150
CHEMENG181 or BIOSCI41 or equivalent
- Quantitative biochemistry and cellular physiology
- Elemental stoichiometry of metabolism
- Fermentation development and control
- Product isolation and purification
- Protein folding and formulation
Note on Course Availability
The course schedule is displayed for planning purposes – courses can be modified, changed, or cancelled. Course availability will be considered finalized on the first day of open enrollment. For quarterly enrollment dates, please refer to our graduate education section.
|Dates:||January 11 - March 19, 2021|
Pre-registration for this course will secure your enrollment request and ensure timely processing of your application for potential course approval. Please note: course enrollment will be confirmed after December 11, 2020; after completing your pre-registration, no further action is required on your part.
This course may not currently be available to learners in some states and territories.